$CLMT

Why Calumet Stock Topped the Market Today

Calumet (CLMT) stock rose 3% after the EPA granted full exemptions for two refineries, removing 71 million RINs from its balance sheet. The company values remaining RINs at $309 million. Calumet is also seeking exemptions for 2022-2024, which are under review. The exemptions improve its financials by reducing compliance costs.

Original reporting
Published Sep 2, 2026, 10:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 10:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Calumet Stock Topped the Market Today — source image
Decision brief

The 30-second read

$CLMTBullishMed
01

Why it matters

The exemption removes 71M RINs from the balance sheet, valued at $309M, improving financial metrics and prompting a 3% stock rise.

02

Market read

Regulatory win boosts CLMT's balance sheet and triggers a short-term price rally.

03

What to watch

Potential future EPA policy tightening could limit further exemptions, and the RIN market volatility may affect realized value.

Relevance 7/10Novelty 7/10Timing: same-day

Background

Calumet (NASDAQ: CLMT) is an oil products specialist that benefits from EPA small refinery exemptions.

Company-level read

Ticker impact

$CLMTBullishHigh confidence
Context

EPA granted full exemptions on two refinery petitions, allowing removal of 71M RINs valued at $309M and boosting CLMT's balance sheet.

Expected impact

Potential upside of 3-5% as investors price in lower compliance costs.

Evidence & confidence

The exemption directly cuts future RIN purchases, a material cost line, and the market already reacted with a 3% rise.

Market effects

Small refinery exemption could set precedent for peers, modestly easing compliance cost concerns in the refining sector.

U.S. refining market sees slight cost relief; limited impact beyond the sector.

Low global relevance; primarily a U.S. regulatory story.

Counterpoint

Exemptions may be challenged legally, creating future uncertainty that could reverse the price gain.

Key entities

  • Calumet

    Oil products specialist receiving EPA exemptions.

  • EPA

    U.S. Environmental Protection Agency granting refinery exemptions.

Related articles

$CLMTHighAI 8/10

Calumet reports Q2 EPS ($1.09) vs. ($1.70) last year

Calumet Specialty Products Partners (CLMT) reported Q2 EPS of ($1.09), an improvement from ($1.70) last year. Revenue rose to $1.45B from $1.03B. CEO Todd Borgmann highlighted strong margin performance and debt reduction. The company's Montana Renewables unit completed the first phase of a fuel expansion project.

$CLMTMed

Calumet stock hits 52-week high at 54.72 USD

Calumet Specialty Products Partners (CLMT) hit a 52-week high of $54.72, up 205.27% over the past year. The company reported Q2 2026 revenue of $1.44B, beating estimates, but missed earnings expectations. S&P upgraded its credit rating to 'B-', while UBS and TD Cowen raised price targets to $47 and $40, respectively, with Neutral/Hold ratings.

$CLMTMed

Q2 Earnings Highlights: Calumet (NASDAQ:CLMT) Vs The Rest Of The Infrastructure Stocks

Calumet (CLMT) stock rose 8.9% post-earnings, trading at $16.19. Kodiak Gas Services (KGS) reported $391.1M revenue, up 21.1% YoY, with stock up 10.5% to $62.81. Excelerate Energy (EE) saw $329.3M revenue, up 61% YoY, with stock up 3% to $39.65. DHT Holdings (DHT) reported $255.2M revenue, up 174% YoY, with stock up 13% to $20.19. Market focus has shifted from AI to geopolitics and back to fundamentals.